RankAlpha logo
Back to Rankings

GRAL

GRAILD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
GRAL vs peer average
41/100
GRAL vs. peer average (D vs. C)
Grade spread
A 2 · B 1 · C 1 · D 1 · F 4
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

ARQT is the first available peer comparator.

Arcutis is a loose same-cap biotech comparator from the packet, but not a direct multi-cancer early detection peer; GRAL should trade more on Galleri-specific regulatory and commercialization milestones than broad biotech beta.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerARQTArcutis Biotherapeutics
GRAL
GRAIL
ARQT
Arcutis Biotherapeutics
Grade
D
B
Momentum
66
14
Value
41
57
Sentiment
41
81
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs ARQT

GRAL / ARQT
Grade Position
Below peers
GRAL vs. peer average (D vs. C)
41/100
Momentum
66
GRAL
Value
41
ARQT
Sentiment
41
ARQT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GRAL
1
ARQT
ARQT
B
80/100
-2
2
ELVN
ELVN
F
20/100
+1
3
IRON
IRON
D
40/100
Even
4
IMNM
Immunome Inc Common
A
100/100
-3
5
TARS
Tarsus Pharmaceuticals Inc Common
C
60/100
-1
ARQT is the first peer returned for this comparison set.